SEQSTER and Audacity Health Partner to Accelerate Clinical Trial Recruitment for Pharma Sponsors

" Teaming up with SEQSTER allows us to combine their cutting-edge technology with our digital strategies to the forefront of clinical research. This partnership is about empowering patients to improve recruitment and accelerate medical breakthroughs through data collection and sharing," said Jill Collins, CEO of Audacity Health.

Collaboration raises study awareness and enhances patient recruitment through powerful digital branding and targeted marketing

San Diego, CA – March 12, 2024 – SEQSTER PDM Inc. (“SEQSTER”), the leading patient-centric healthcare technology company today announced a strategic partnership with Audacity Health, a renowned digital branding and patient recruitment company at the 2024 Healthcare Information and Management Systems Society (HIMSS) Annual Conference and exhibition. This powerful alliance will significantly enhance SEQSTER's digital marketing and patient engagement capabilities, fueling broader awareness and accelerating enrollment in life-changing clinical trials and studies.

Audacity Health will provide a comprehensive suite of services to amplify SEQSTER's digital presence and accelerate patient recruitment:

  • Patient-Centric Recruitment: Custom-tailored recruitment + patient-friendly messaging to lead to better engagement.
  • Optimized Digital Branding: Amplify SEQSTER studies and trials, while ensuring a seamless user experience for the enrollment process.
  • Precision Digital Marketing: Targeted social media campaigns, content strategies, and search engine optimization (SEO) will elevate patient awareness.
  • Data-Driven Insights: Detailed reporting and analytics will allow the refinement of marketing strategies for optimal results.

"Our partnership with Audacity Health empowers patients to take the first step towards participating in potentially life-altering clinical trials. By making it easier to find and understand relevant studies, we’re removing barriers to progress in medical research, ultimately helping bring new treatments to those who need them," stated Ardy Arianpour, CEO & Co-Founder of SEQSTER.

"Teaming up with SEQSTER allows us to combine their cutting-edge technology with our digital strategies to the forefront of clinical research. This partnership is about empowering patients to improve recruitment and accelerate medical breakthroughs through data collection and sharing," said Jill Collins, CEO of Audacity Health.

This marks a turning point in patient engagement for clinical trials. SEQSTER and Audacity Health are positioned to transform healthcare by making research more accessible and patient-centered.